Figure 2.
Kaplan-Meier survival curves in CLL according to IGVH mutational status, L/A ratio, or ZAP-70 expression. (A) EFS probabilities for the total population. (B) EFS probabilities for patients in stage A. (C) OS probabilities for patients with stages B and C disease.